Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
No association seen for overall PFAS mixture, but higher midlife weight seen per doubling of PFOS, 2-(N-ethyl-perfluorooctane sulfonamido) acetate
Read More »Specific PFAS Differentially Affect Maternal Midlife Adiposity
Skin Care Product Use by Children Tied to Phthalates/Replacement Metabolites
SCP use associated with urinary phthalate/replacement metabolites among young children
Read More »High Insulin Levels Genetically Linked to Lower Lipoprotein(a)
Authors say inverse association may be explained by hyperinsulinemia
Read More »SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes
Findings show greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors
Read More »Interleukin-6 May Boost Prediction of Obesity-Related Cancers
Findings seen among patients with newly diagnosed type 2 diabetes
Read More »Chronic Diabetes Complications Bidirectionally Linked to Mental Health Disorders
Findings seen across the life span and irrespective of diabetes type
Read More »Meat Consumption Linked to Increased Incidence of Type 2 Diabetes
Risk increased in association with consumption of 100 g/day red meat, 50 g/day processed meat
Read More »Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price
By Ernie Mundell HealthDay ReporterTUESDAY, Aug. 27, 2024 (HealthDay News) — Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers.The new 2.5 milligram (mg) and 5 mg weekly dose …
Read More »FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type 2 Diabetes
Omnipod 5 works in concert with a continuous glucose monitor to manage blood glucose with no daily injections and no finger pricks
Read More »Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DM
Estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults
Read More »